|
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device off-label, migration, and inadvertently puncturing the bone or tissue during the procedure have been ruled out as potential causes.Additionally, picking or touching the wound and the patient having contraindicating conditions have been ruled out.However, non-compliance to the ifu was identified as the surgical site was closed using steri-strips and tegaderm.Per the freedom peripheral nerve stimulator system implantation of neurostimulator instructions for use, 05-20200 rev.7 "close the incisions using sterile skin closures and apply dressings.Closures are usually done in two steps, with absorbable sutures for the deeper layer and either nonabsorbable or absorbable sutures for the superficial layer." a curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.Although the cause of the reported issue is unknown, non-compliance to the ifu was identified as the surgical site was closed with steri-strips and tegaderm (user error-clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
|